Insider: Struthers Richard Scott President & CEO - Crinetics Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 329,147 | 100,000 | 429,147 |
| Value | $14,826,426.62 | $4,504,500.00 | $19,330,926.62 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/19/2025 | DDS | 875 | Direct | COM | $34.83 | $30,476.25 | 329,147 |
| 03/19/2025 | DDS | 16,463 | Direct | COM | $34.17 | $562,540.71 | 330,022 |
| 12/02/2024 | DDS | 10,000 | Indirect | COM | $57.57 | $575,700.00 | 100,000 |
| 05/08/2024 | DDS | 107,448 | Direct | COM | $49.40 | $5,307,931.20 | 257,485 |
| 04/04/2024 | DDS | 40,951 | Direct | COM | $49.17 | $2,013,560.67 | 237,835 |
| 11/03/2023 | DDS | 199,082 | Direct | COM | $30.56 | $6,083,945.92 | 135,522 |
| 11/02/2023 | DDS | 918 | Direct | COM | $29.95 | $27,494.10 | 135,522 |
| 07/13/2023 | DDS | 14,157 | Indirect | COM | $20.35 | $288,094.95 | 630,805 |
| 07/12/2023 | DDS | 11,459 | Indirect | COM | $20.17 | $231,128.03 | 644,962 |
| 07/11/2023 | DDS | 24,384 | Indirect | COM | $20.14 | $491,093.76 | 656,421 |
| 06/16/2023 | DDS | 50,000 | Indirect | COM | $20.81 | $1,040,500.00 | 680,805 |
| 04/13/2022 | DDS | 24,674 | Indirect | COM | $25.42 | $627,329.05 | 844,774 |
| 04/13/2022 | DDS | 69,176 | Indirect | COM | $27.53 | $1,904,256.18 | 730,805 |
| 04/13/2022 | DDS | 44,793 | Indirect | COM | $26.52 | $1,188,040.26 | 799,981 |
| 04/05/2022 | DDS | 21,357 | Indirect | COM | $25.34 | $541,224.82 | 869,448 |
| 09/07/2021 | DDS | 10,000 | Indirect | COM | $25.00 | $250,000.00 | 90,000 |
| 09/07/2021 | DDS | 10,000 | Indirect | COM | $25.00 | $250,000.00 | 90,000 |
| 09/07/2021 | DDS | 10,000 | Indirect | COM | $25.00 | $250,000.00 | 90,000 |
| 07/16/2020 | DDS | 17,500 | Indirect | COM | $14.46 | $253,107.75 | 890,805 |
| 07/15/2020 | DDS | 17,500 | Indirect | COM | $15.30 | $267,722.00 | 908,305 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research